| Advances in development of rechargeable mitochondrial antioxidants AN Lukashev, MV Skulachev, V Ostapenko, AY Savchenko, ... Progress in molecular biology and translational science 127, 251-265, 2014 | 38 | 2014 |
| Protective C allele of the single-nucleotide polymorphism rs1335532 is associated with strong binding of Ascl2 transcription factor and elevated CD58 expression in B-cells NA Mitkin, AM Muratova, KV Korneev, VV Pavshintsev, KA Rumyantsev, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (10 …, 2018 | 22 | 2018 |
| Effects of mitochondrial antioxidant SkQ1 on biochemical and behavioral parameters in a Parkinsonism model in mice VV Pavshintsev, LS Podshivalova, OY Frolova, MV Belopolskaya, ... Biochemistry (Moscow) 82, 1513-1520, 2017 | 14 | 2017 |
| Individual roles of brain and serum alcohol dehydrogenase isoforms in regulation of alcohol consumption in SPF Wistar rats VV Pavshintsev, NA Mitkin, OY Frolova, EA Kushnir, OA Averina, ... Physiology & behavior 179, 458-466, 2017 | 12 | 2017 |
| Peptide LCGA-17 attenuates behavioral and neurochemical deficits in rodent models of PTSD and depression AV Malyshev, IA Sukhanova, VM Ushakova, YA Zorkina, OV Abramova, ... Pharmaceuticals 15 (4), 462, 2022 | 11 | 2022 |
| In silico Screening and Behavioral Validation of a Novel Peptide, LCGA-17, With Anxiolytic-Like Properties AV Malyshev, IA Sukhanova, AS Zlobin, VR Gedzun, VV Pavshintsev, ... Frontiers in Neuroscience 15, 705590, 2021 | 10 | 2021 |
| Active immunization against serum alcohol dehydrogenase normalizes brain dopamine metabolism disturbed during chronic alcohol consumption NA Mitkin, PK Anokhin, MV Belopolskaya, OY Frolova, EA Kushnir, ... Alcohol 83, 17-28, 2020 | 8 | 2020 |
| The novel peptide chm-273s has therapeutic potential for metabolic disorders: evidence from in vitro studies and high-sucrose diet and high-fat diet rodent models NA Mitkin, VV Pavshintcev, IA Sukhanova, II Doronin, GA Babkin, ... Pharmaceutics 14 (10), 2088, 2022 | 2 | 2022 |
| P. 068 Stress-protective effects of a novel peptide GABAergic system modulator in animal models of anxiety, depression and post-traumatic stress disorder A Malyshev, C Haile, I Sukhanova, I Doronin, V Gedzun, N Mitkin, ... European Neuropsychopharmacology 40, S44-S45, 2020 | 2 | 2020 |
| Experimental Studies of the Effects of the Dopamine D2 Receptor Agonist Cabergoline on Catecholamine Content and BDNF mRNA Expression in the Midbrain … PK Anokhin, AG Veretinskaya, VV Pavshintsev, IY Shamakina Neuroscience and Behavioral Physiology 50, 830-834, 2020 | 2 | 2020 |
| The effect of the dopamine D2 receptor agonist cabergoline on the content of catecholamines and expression of BDNF mRNA in the rat midbrain and hypothalamus PK Anokhin, AG Veretinskaya, VV Pavshintsev, IY Shamakina Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 119 (11), 54-59, 2019 | 2 | 2019 |
| Effect of SkQ1 Antioxidant on Structural and Functional Conditions of The Brain in PostResuscitation Period ML Lovat, MS Avrushchenko, OA Averina, VV Pavshintsev, IV Ostrova, ... General Reanimatology 12 (2), 6-19, 2016 | 2 | 2016 |
| The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models AV Malyshev, VV Pavshintcev, NA Mitkin, IA Sukhanova, VR Gedzun, ... Frontiers in Behavioral Neuroscience 18, 1333258, 2024 | 1 | 2024 |
| From land to water:“sunken” T-maze for associated learning in cichlid fish VR Gedzun, IA Sukhanova, GM Aliper, MM Kotova, NO Melnik, ... Behavioural Brain Research, 115077, 2024 | | 2024 |
| Chronic administration of the novel hypoglycaemic peptide exhibits robust efficacy in a diet-induced model of obesity and type 2 diabetes N Mitkin, V Pavshintsev, I Doronin, G Babkin, A Malyshev DIABETOLOGIA 65 (SUPPL 1), S313-S314, 2022 | | 2022 |
| 111-LB: CHM-273S Peptide Decreases Blood Glucose Level, Improves Insulin Sensitivity, and Induces Insulin Signaling Pathways in the Liver of Rats with Diet-Induced Metabolic … V Pavshintsev, N Mitkin, I Doronin, E Emelianova, M Lovat, G Babkin, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models … NA Mitkin, VV Pavshintcev, IA Sukhanova, II Doronin, GA Babkin, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Novel hypoglycemic peptide acts as an appetite regulator in mice applying Stat3 pathway in hypothalamus V Pavshintsev, N Mitkin, I Doronin, G Babkin, A Malyshev Neuroscience Applied 1, 100160, 2022 | | 2022 |
| P. 0417 Novel peptide with anxiolytic-like properties prevented behavioral despair in rats after chronic restraint stress through alterations in the synaptic plasticity AV Stavrovskaya, AV Malyshev, AS Gushchina, I Sukhanova, NA Mitkin, ... European Neuropsychopharmacology 53, S302-S303, 2021 | | 2021 |
| Serum of Mice Immunized with MT1-MMP Metalloproteinase Reduces Migration Potential of Pancreatic Cancer Cells NA Mitkin, AS Ustiugova, AN Uvarova, KA Rumyantsev, KV Korneev, ... Molecular Biology 55, 910-918, 2021 | | 2021 |
